Polynovo Limited (ASX: PNV)
Sector: Health Care
Market cap: A$625M (as of 2 Nov 2026)
PolyNovo develops and commercialises innovative medical devices using its NovoSorb technology in the treatment of burns, surgical wounds and Negative Pressure Wound Therapy.
Data as of 2 Nov 2026.
Recent capital raises
| Date | Type | Amount | Price | Discount | Source |
|---|---|---|---|---|---|
| 16 Dec 2022 | SPP | $20M | $1.90 | — | Filing ↗ |
Substantial holders — latest moves
| Date | Holder | Move | Holding | Source |
|---|---|---|---|---|
| 27 Oct 2026 | FIL Limited | Decrease | 8.64% → 7.6% | Filing ↗ |
| 29 June 2026 | FIL Limited and its entities listed in Annexure A ("FIL") | Decrease | 9.65% → 8.64% | Filing ↗ |
| 23 Sept 2025 | State Street Corporation and subsidiaries named in paragraph 6 to this form | Decrease | 7.16% → 6.15% | Filing ↗ |
| 22 Sept 2025 | State Street Corporation and subsidiaries named in paragraph 6 to this form | Increase | 6.06% → 7.16% | Filing ↗ |
| 29 Aug 2025 | UBS Group AG and its related bodies corporate | Entry | ?% → 6.53% | Filing ↗ |
Director trades — on-market
| Date | Director | Trade | Source |
|---|---|---|---|
| 12 Mar 2026 | Robert (Rob) Douglas | Bought 151,000 fully paid ordinary shares | Filing ↗ |
| 25 Feb 2026 | Mr Leon Hoare | Bought 30,000 | Filing ↗ |
| 24 Feb 2026 | Mr Andrew Lumsden | Bought 100,000 fully paid ordinary shares | Filing ↗ |
| 19 Sept 2025 | David John Williams | Bought 55,000 | Filing ↗ |
| 17 Sept 2025 | Dr Robyn Elliott | Bought 20,000 ordinary fully paid shares | Filing ↗ |
Ask about PNV in Claude or ChatGPT
Add the Capital Signal connector at https://capitalsignal.io/api/mcp, then ask:
- Has PNV raised money in the last year, and at what discount?
- What was PNV's latest cash position and runway?
Loading PNV…